To test whether TAMs can present tumor antigens on MHC class II to effector CD4 T cells at the tumor site and the consequences of such interaction, we used a previously described mouse model where Marilyn CD4 T cells, specific for the male antigen H-Y, is very efficient rejecting H-Y–expressing tumors (1). This evidence concerns the gene CD4 and neoplasm.